The PCICURE
study8 has provided the best data
to date regarding the benefit of continuing
clopidogrel and aspirin beyond
4 weeks after PCI, with patients
taking clopidogrel for a mean of 9
months (maximum, 1 year) experiencing
an overall 31% relative reduction
in the risk of cardiovascular death, myocardial
infarction (MI), and stroke